UPLC Technology, which has been adopted successfully in clinical laboratories around the world for the most demanding separations, is highly robust, dependable, and provides reproducible results.
The ACQUITY UPLC System eliminates significant time and cost per sample from your analytical process while providing high quality results. By outperforming traditional or optimized HPLC, this technology allows chromatographers to work at higher efficiencies with a much wider range of linear velocities, flow rates, and backpressures.
UPLC Technology, which has been adopted successfully in laboratories around the world for the most demanding separations, is highly robust, dependable, and provides reproducible results. What differentiates the holistic design of the ACQUITY UPLC System is Waters’ patented sub-2-μm hybrid particle chemistry, which offers significant benefits over today's HPLC systems equipped with standard 5-μm particle chemistries.
The ACQUITY UPLC System, used with Waters IVD labeled MS detection technologies and consumables, provides unique end-to-end solutions for clinical laboratories.
Since its introduction in 2004, UPLC Technology has enabled analytical chemists to reach far beyond conventional HPLC separations. Recognizing the challenges presented by the revalidation of methods, Waters continues to manufacture, sell, and support the ACQUITY UPLC System over 10 years after UPLC Technology was released to the market.
Waters follows internationally recognized standards with respect to its medical devices.
For in vitro diagnostic use. Not available in all countries. For information on availability, please contact your local representative.